Skip to main content
. 2015 Dec 28;2016:1635361. doi: 10.1155/2016/1635361

Figure 2.

Figure 2

Effects of metformin (MET), glibenclamide (GLI), and repaglinide (REP) on serum catalase activity. Data are expressed as mean ± SEM (n = 6), p < 0.05 when compared with control group.